NFKB1 and atherosclerosis: Mechanistically, DHL effectively alleviates atherosclerosis by promoting cholesterol efflux and inhibiting inflammation through the TLR2/PPAR-γ/NF-κB signaling pathway, which suggests that DHL may serve as a new treatment strategy for atherosclerosis (As seen in Graphic abstract).